Effect of insulin and epidermal growth factors on the synthesis of glycosaminoglycans/proteoglycans in cultured human malignant mesothelioma cells of different phenotypic morphology

APMIS

Volumn 104, Issue 10, 1996, Pages 718-728

  Tzanakakis, George N ^a   Karamanos, Nikos K ^b   Syrokou, Alexandra ^b   Hjerpe, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Differentiation; Glycosaminoglycan; Growth factor; Mesothelioma; Proteoglycan; Synthesis

Indexed keywords

GALACTOSAMINOGLYCAN; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HYALURONIC ACID; PROTEOGLYCAN; RECOMBINANT EPIDERMAL GROWTH FACTOR; RECOMBINANT SOMATOMEDIN C;

ARTICLE; CANCER CELL CULTURE; CYTOLOGY; HUMAN; HUMAN CELL; MESOTHELIOMA; PRIORITY JOURNAL;

EID: 0029796776     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1996.tb04934.x     Document Type: Article

References (39)

1. Adams, J. C. & Watt, F.: Regulation of development and differentiation by the extracellular matrix. Development 117: 1183-1198, 1993.
2. Aizenman, Y., Weichsel, M. E. Jr. & deVellis, J.: Changes in insulin and transferrin requirements of pure brain neuronal cultures during embryonic development. Proc. Natl. Acad. Sci. USA 83: 2263-2266, 1986.
3. Antonopoulos, C. A., Borelious, E., Hamnström, B. & Scott, J. E.: The precipitation of polyanions by long-chain aliphatic ammonium compounds. Elution in salt solutions of mucopolysaccharide-quaternary ammonium complexes absorbed on a support. Biochim. Biophys. Acta 54: 213-226, 1961.
4. Asplund, T., Versnel, M. A., Laurent, T. C. & Heldin, P.: Human mesothelioma cells produce factors that stimulate the production of hyaluronan by mesothelial cells and fibroblasts. Cancer Res. 53: 388-392, 1993.
5. Carpenter, G. & Cohen, S.: Epidermal growth factor. Annu. Rev. Biochem. 48: 193-216, 1989.
6. Corps, A. N. & Brown, K. D.: Insulin-like growth factor I and insulin reduce epidermal growth factor binding to Swiss 3T3 cells by an indirect mechanism that is apparently independent of protein kinase C. FASEB. J. 233: 303-306, 1988.
7. David, G.: Integral membrane heparan sulfate proteoglycans. FASEB. J. 7: 1023-1030, 1993.
8. Freboug, T., Lerebours, G., Delpech, B., Benhamou, D., Bertrand, P., Maingonnat, C., Boutin, C. & Nouvet, G.: Serum hyaluronate in malignant pleural mesothelioma. Cancer 59: 2104-2107, 1987.
9. Froesch, E. R., Schmid, C., Schwander, J. & Zapf, J.: Actions of insulin-like growth factors. Ann. Rev. Physiol. 47: 443-467, 1985.
10. Gervin, B. I., Lechner, J. F., Reddel, R. R., Roberts, A. B., Robbins, K. C., Gabrielson, E. W. & Harris, C. C.: Comparison of production of transforming growth factor-b and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines. Cancer Res. 47: 6180-6184, 1987.
11. Gita-Goren, H., Soker, S., Vlodavsky, I. & Neufeld, G.: The binding of vascular endothelial growth factor to its receptor is dependent on cell surface-associated heparin-like molecules. J. Biol. Chem. 267: 6093-6098, 1992.
12. Hashimoto, N., Morikava, K., Kikuchi, M., Yoshida, K. & Tokuyasu, K.: Purification and properties of a new keratan sulfate degrading enzyme. Seikagaku 60: 935, 1988.
13. Hjerpe, A.: Liquid-chromatographic determination of hyaluronic acid in pleural and ascitic fluids. Clin. Chem. 32: 952-956, 1986.
14. Hjerpe, A., Antonopoulos, C. A. & Engfeldt, B.: The determination of hyaluronic acid using high-performance liquid chromatography of chondroitinase digests. J. Chromatogr. 245: 193-195, 1982.
15. Honda, A., Noguchi, N., Takehara, H., Ohashi, Y., Asuwa, N. & Mori, Y.: Cooperative enhancement of hyaluronic acid synthesis by combined use of IGF-I and EGF, and inhibition by tyrosine kinase inhibitor genistein, in cultured mesothelial cells from rabbit pericardial cavity. J. Cell Sci. 98: 91-98, 1991.
16. Karamanos, N. K., Syrokou, A., Vanky, P., Nurminen, M. & Hjerpe, A.: Determination of 24 variously sulfated galactosaminoglycan- and hyaluronan-derived disaccharides by high-performance liquid chromatography. Anal. Biochem. 221: 189-199, 1994.
17. Kjellén, L. & Lindahl, U.: Proteoglycans: Structures and interactions. Annu. Rev. Biochem. 60: 443-475, 1991.
18. Klominek, J., Robert, K.-H., Hjerpe, A., Wikström, B. & Gahrton, G.: Serum-dependent growth patterns of two, newly established human mesothelioma cell lines. Cancer Res. 49: 6118-6122, 1989.
19. Linker, A. & Conrand, H. E.: Heparinase and heparitinase from flavobacteria. Methods Enzymol. 28: 902-911, 1972.
20. McMorris, A. F., Smith, T. M., DeSalvo, S. & Furlanetto, R. W.: Insulin-like growth factor I/ somatomedin C: A potent inducer of oligodendrocyte development. Proc. Natl. Acad. Sci. USA 83: 822-826, 1986.
21. Moscatelli, D., Presta, M., Joseph-Silverstein, J. & Rifkin, D. B.: Both normal and tumor cells produce basic fibroblast growth factor. J. Cell. Physiol. 129: 273-276, 1986.
22. Nicolson, G. L: Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis. Exp. Cell. Res. 204: 171-180, 1993.
23. Nurminen, M., Dejmek, A., Mårtensson, G., Thylen, A. & Hjerpe, A.: Clinical utility of liquid-chromatographic analysis of effusions for hyaluronate content. Clin. Chem. 40: 777-780, 1994.
24. Papanicolau, G. N.: A new procedure for staining vaginal smears. Science 95: 438-439, 1942.
25. Pathak, M. A., Matrisian, L. M., Magun, B. E. & Salmon, S. E.: Effect of epidermal growth factor on clonogenic growth of primary human tumor cells. Int. J. Cancer 30: 745-750, 1982.
26. Poole, A. R.: Proteoglycans in health and disease: structure and function. Biochem. J. 236: 1-14, 1986.
27. Prehm, P.: Hyaluronate is synthesized at the plasma membrane. Biochem. J. 220: 597-600, 1984.
28. Rapraeger, A. C., Krufka, A. & Olwin, B. B.: Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252: 1705-1708, 1991.
29. Sakagushi, K., Yanagishita, M., Takeuchi, Y. & Aurbach, G. D.: Identification of heparan sulphate proteoglycan as a high affinity receptor for acidic fibroblast growth factor (aFGF) in a parathyroid cell line. J. Biol. Chem. 266: 7270-7278, 1991.
30. Saksela, O., Moscattelli, D., Sommer, A. & Rifkin, D. B.: Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J. Cell Biol. 107: 743-751, 1988.
31. Scott, J. E.: In: Glick, D. (Ed.): Methods for Biochemical Analysis, Vol. 8. Interscience, New York, 1960, pp 145-197.
32. Shively, J. E. & Conrand, H. E.: Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry 15: 3932-3942, 1976.
33. Tzanakakis, G. N., Karamanos, N. K., Klominek, J. & Hjerpe, A.: Glycosaminoglycans from two human malignant mesothelioma cell lines: determination, distribution, and effect of platelet-derived growth factor on their synthesis. Biochem. Cell Biol. 73: 59-66, 1995.
34. Tzanakakis, G. N., Karamanos, N. K. & Hjerpe, A.: Effects on glycosaminoglycan synthesis in cultured human malignant mesothelioma cells of transforming, epidermal and fibroblast growth factors and their combination with platelet-derived growth factor. Exp. Cell Res. 220: 130-137, 1995.
35. Vlodavsky, I., Bar-Shavit, R., Ishai-Micharli, R., Bashkin, P. & Fuks, Z.: Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends Biochem. Sci. 16: 268-271, 1991.
36. Volpi, N., Petrini, M., Conte, A., Valentini, P., Venturelli, T., Bolognani, L. & Ronca, G.: Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship. Exp. Cell Res. 215: 119-130, 1994.
37. Wight, T. N., Kinsella, M. G. & Qwarnstrom, E. E.: The role of proteoglycans in cell adhesion, migration and proliferation. Curr. Opin Cell Biol. 4: 793-801, 1992.
38. Yamagata, T., Saito, H., Habuchi, O. & Suzuki, S.: Purification and properties of bacterial chondroitinases and chondrosulfatases. J. Biol. Chem. 243: 1523-1535, 1968.
39. Yayon, A., Klagsburn, M., Esko, J. D., Leder, P. & Ornitz, D. M.: Cell surface heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64: 841-848, 1991.